Disopyramide pharmacokinetics in patients with acute myocardial infarction View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1985-01

AUTHORS

P. J. Pentikäinen, H. Huikuri, A. J. Jounela, G. Wilen

ABSTRACT

To study the effects of acute myocardial infarction on the pharmacokinetics of disopyramide a single oral dose of disopyramide base (200 mg) was administered to 6 patients with myocardial infarction both in the acute (Study I) and recovery (Study II) phases. An intravenous tracer dose of 14C-disopyramide (2.5 micrograms/0.3 mg) was given simultaneously with the oral dose. On the basis of the intravenous tracer data, the volume of distribution, binding to plasma proteins, total plasma clearance, renal clearance and elimination half-life of disopyramide and mono-N-dealkyl disopyramide were the same in Studies I and II. The peak serum concentrations of disopyramide after oral dosing in Studies I and II were 2.6 +/- 1.2 (SEM) and 6.4 +/- 1.9 microgram/ml, respectively (p less than 0.05), the peak times 3.29 +/- 1.22 and 1.21 +/- 0.39 h (N.S.) and the AUCINF 38.0 +/- 7.7 and 60.7 +/- 9.9 micrograms . h . ml-1 (p less than 0.05). The recovery of disopyramide in urine over 3 days averaged 46% and 47% of dose, and that of mono-N-dealkyl disopyramide 22% and 16% of the dose, respectively. Thus, the gastrointestinal absorption of disopyramide was disturbed, resulting in low plasma concentrations after oral dosing, whereas the elimination of disopyramide was unaltered in the acute phase of myocardial infarction. More... »

PAGES

45-51

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00635707

DOI

http://dx.doi.org/10.1007/bf00635707

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1052371540

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/3987785


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biotransformation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Creatinine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disopyramide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemodynamics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Injections, Intravenous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kinetics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myocardial Infarction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Saliva", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ultrafiltration", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Helsinki", 
          "id": "https://www.grid.ac/institutes/grid.7737.4", 
          "name": [
            "Third Department of Medicine, University of Helsinki, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pentik\u00e4inen", 
        "givenName": "P. J.", 
        "id": "sg:person.0105361047.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0105361047.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Oulu", 
          "id": "https://www.grid.ac/institutes/grid.10858.34", 
          "name": [
            "Department of Medicine, University of Oulu, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Huikuri", 
        "givenName": "H.", 
        "id": "sg:person.01127603173.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127603173.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Oulu", 
          "id": "https://www.grid.ac/institutes/grid.10858.34", 
          "name": [
            "Department of Medicine, University of Oulu, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jounela", 
        "givenName": "A. J.", 
        "id": "sg:person.063042215.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.063042215.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Star Pharmaceutical Co., Tampere, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wilen", 
        "givenName": "G.", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1111/j.1365-2125.1982.tb02024.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002298390"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-197702050-00004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006080251", 
          "https://doi.org/10.2165/00003088-197702050-00004"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-197702050-00004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006080251", 
          "https://doi.org/10.2165/00003088-197702050-00004"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-197601060-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007331153", 
          "https://doi.org/10.2165/00003088-197601060-00001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0021-9673(00)82914-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011004768"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00613425", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012081526", 
          "https://doi.org/10.1007/bf00613425"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00613425", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012081526", 
          "https://doi.org/10.1007/bf00613425"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0021-9673(01)91823-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012518873"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00566315", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013146099", 
          "https://doi.org/10.1007/bf00566315"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00566315", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013146099", 
          "https://doi.org/10.1007/bf00566315"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cpt1975176669", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022507357"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1749-6632.1971.tb46914.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029210020"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9149(78)90851-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032568018"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(69)90318-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050812373"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(69)90318-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050812373"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cpt19792611", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052709492"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/ac50039a032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055010436"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003495-197815050-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069122835", 
          "https://doi.org/10.2165/00003495-197815050-00002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-78-4-499", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073730779"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074400604", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074400615", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082154003", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1985-01", 
    "datePublishedReg": "1985-01-01", 
    "description": "To study the effects of acute myocardial infarction on the pharmacokinetics of disopyramide a single oral dose of disopyramide base (200 mg) was administered to 6 patients with myocardial infarction both in the acute (Study I) and recovery (Study II) phases. An intravenous tracer dose of 14C-disopyramide (2.5 micrograms/0.3 mg) was given simultaneously with the oral dose. On the basis of the intravenous tracer data, the volume of distribution, binding to plasma proteins, total plasma clearance, renal clearance and elimination half-life of disopyramide and mono-N-dealkyl disopyramide were the same in Studies I and II. The peak serum concentrations of disopyramide after oral dosing in Studies I and II were 2.6 +/- 1.2 (SEM) and 6.4 +/- 1.9 microgram/ml, respectively (p less than 0.05), the peak times 3.29 +/- 1.22 and 1.21 +/- 0.39 h (N.S.) and the AUCINF 38.0 +/- 7.7 and 60.7 +/- 9.9 micrograms . h . ml-1 (p less than 0.05). The recovery of disopyramide in urine over 3 days averaged 46% and 47% of dose, and that of mono-N-dealkyl disopyramide 22% and 16% of the dose, respectively. Thus, the gastrointestinal absorption of disopyramide was disturbed, resulting in low plasma concentrations after oral dosing, whereas the elimination of disopyramide was unaltered in the acute phase of myocardial infarction.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/bf00635707", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1054337", 
        "issn": [
          "0031-6970", 
          "1432-1041"
        ], 
        "name": "European Journal of Clinical Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "28"
      }
    ], 
    "name": "Disopyramide pharmacokinetics in patients with acute myocardial infarction", 
    "pagination": "45-51", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "f976642354b7248045940bcea3cc3ec82e5448f2f06b794c82243aec82e6c6fb"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "3987785"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "1256165"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00635707"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1052371540"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00635707", 
      "https://app.dimensions.ai/details/publication/pub.1052371540"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:17", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000372_0000000372/records_117092_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/BF00635707"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00635707'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00635707'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00635707'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00635707'


 

This table displays all metadata directly associated to this object as RDF triples.

210 TRIPLES      21 PREDICATES      62 URIs      36 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00635707 schema:about N0fea0961ac5e4ca79d43ff232833abf0
2 N0ff6bb7c14c34887a7d23afbdd323638
3 N1fccb301131e4d39849234697f694983
4 N215df6038792441d88d282807b4183b4
5 N24a18d1d653d4be1b63b28cc07297e16
6 N296f9d1c64eb44a1909ed56dcebec290
7 N74112588d6194f2a8e6a46debdebd7dc
8 N76375c5d70a74e5ebdae25349dcb0519
9 N8b71f3a3680e462ebb0e6ac761c48f2a
10 Nbdf8db5a346645fc81290a2f99789c4d
11 Ncc982d3848c746eba21e6d8dd4b9c86d
12 Ndc8f32200f5a427584cf66e4b80f8838
13 Ne052ce69553d4db7bde234cab2fcbc9d
14 Ne7c7635808084121a27c3ea6ac54af16
15 Nf889027a37a944cfbc7bf36415606214
16 anzsrc-for:11
17 anzsrc-for:1103
18 schema:author Ncfdacd602176400daf3a7cc726016867
19 schema:citation sg:pub.10.1007/bf00566315
20 sg:pub.10.1007/bf00613425
21 sg:pub.10.2165/00003088-197601060-00001
22 sg:pub.10.2165/00003088-197702050-00004
23 sg:pub.10.2165/00003495-197815050-00002
24 https://app.dimensions.ai/details/publication/pub.1074400604
25 https://app.dimensions.ai/details/publication/pub.1074400615
26 https://app.dimensions.ai/details/publication/pub.1082154003
27 https://doi.org/10.1002/cpt1975176669
28 https://doi.org/10.1002/cpt19792611
29 https://doi.org/10.1016/0002-9149(78)90851-2
30 https://doi.org/10.1016/0006-2952(69)90318-9
31 https://doi.org/10.1016/s0021-9673(00)82914-3
32 https://doi.org/10.1016/s0021-9673(01)91823-0
33 https://doi.org/10.1021/ac50039a032
34 https://doi.org/10.1111/j.1365-2125.1982.tb02024.x
35 https://doi.org/10.1111/j.1749-6632.1971.tb46914.x
36 https://doi.org/10.7326/0003-4819-78-4-499
37 schema:datePublished 1985-01
38 schema:datePublishedReg 1985-01-01
39 schema:description To study the effects of acute myocardial infarction on the pharmacokinetics of disopyramide a single oral dose of disopyramide base (200 mg) was administered to 6 patients with myocardial infarction both in the acute (Study I) and recovery (Study II) phases. An intravenous tracer dose of 14C-disopyramide (2.5 micrograms/0.3 mg) was given simultaneously with the oral dose. On the basis of the intravenous tracer data, the volume of distribution, binding to plasma proteins, total plasma clearance, renal clearance and elimination half-life of disopyramide and mono-N-dealkyl disopyramide were the same in Studies I and II. The peak serum concentrations of disopyramide after oral dosing in Studies I and II were 2.6 +/- 1.2 (SEM) and 6.4 +/- 1.9 microgram/ml, respectively (p less than 0.05), the peak times 3.29 +/- 1.22 and 1.21 +/- 0.39 h (N.S.) and the AUCINF 38.0 +/- 7.7 and 60.7 +/- 9.9 micrograms . h . ml-1 (p less than 0.05). The recovery of disopyramide in urine over 3 days averaged 46% and 47% of dose, and that of mono-N-dealkyl disopyramide 22% and 16% of the dose, respectively. Thus, the gastrointestinal absorption of disopyramide was disturbed, resulting in low plasma concentrations after oral dosing, whereas the elimination of disopyramide was unaltered in the acute phase of myocardial infarction.
40 schema:genre research_article
41 schema:inLanguage en
42 schema:isAccessibleForFree false
43 schema:isPartOf N58e98fe3a12b4809a3eac08dc1fc0045
44 Nc9599eea59704d37a918e61ee15c6afe
45 sg:journal.1054337
46 schema:name Disopyramide pharmacokinetics in patients with acute myocardial infarction
47 schema:pagination 45-51
48 schema:productId N1eb3b87c26c8451ebda284672adaf388
49 N691db87cbc604017aee53c395c4f2f47
50 N90dddb3393e24f3b97d5fb4b8c2efd22
51 Nbbd7182b0b6c4439b6b9d0693da6fa8c
52 Nece4417a103342088beec7484a0e390d
53 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052371540
54 https://doi.org/10.1007/bf00635707
55 schema:sdDatePublished 2019-04-11T14:17
56 schema:sdLicense https://scigraph.springernature.com/explorer/license/
57 schema:sdPublisher Nbfbda98045494b5faebec33ddd2f83ae
58 schema:url http://link.springer.com/10.1007/BF00635707
59 sgo:license sg:explorer/license/
60 sgo:sdDataset articles
61 rdf:type schema:ScholarlyArticle
62 N0fea0961ac5e4ca79d43ff232833abf0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
63 schema:name Middle Aged
64 rdf:type schema:DefinedTerm
65 N0ff6bb7c14c34887a7d23afbdd323638 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Administration, Oral
67 rdf:type schema:DefinedTerm
68 N1eb3b87c26c8451ebda284672adaf388 schema:name pubmed_id
69 schema:value 3987785
70 rdf:type schema:PropertyValue
71 N1fccb301131e4d39849234697f694983 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Ultrafiltration
73 rdf:type schema:DefinedTerm
74 N1ff774273479467aac12ba123b18f60d schema:name Star Pharmaceutical Co., Tampere, Finland
75 rdf:type schema:Organization
76 N215df6038792441d88d282807b4183b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Injections, Intravenous
78 rdf:type schema:DefinedTerm
79 N24a18d1d653d4be1b63b28cc07297e16 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Disopyramide
81 rdf:type schema:DefinedTerm
82 N296f9d1c64eb44a1909ed56dcebec290 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Hemodynamics
84 rdf:type schema:DefinedTerm
85 N3c6103e7a9194f59bf1bc68a8862c0aa rdf:first Ne819ab9b83994081b14fb8152d799da6
86 rdf:rest rdf:nil
87 N58e98fe3a12b4809a3eac08dc1fc0045 schema:issueNumber 1
88 rdf:type schema:PublicationIssue
89 N691db87cbc604017aee53c395c4f2f47 schema:name readcube_id
90 schema:value f976642354b7248045940bcea3cc3ec82e5448f2f06b794c82243aec82e6c6fb
91 rdf:type schema:PropertyValue
92 N74112588d6194f2a8e6a46debdebd7dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Saliva
94 rdf:type schema:DefinedTerm
95 N76375c5d70a74e5ebdae25349dcb0519 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Adult
97 rdf:type schema:DefinedTerm
98 N8b71f3a3680e462ebb0e6ac761c48f2a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Female
100 rdf:type schema:DefinedTerm
101 N90dddb3393e24f3b97d5fb4b8c2efd22 schema:name nlm_unique_id
102 schema:value 1256165
103 rdf:type schema:PropertyValue
104 N9ef88f1e50bd45ca9b2f93f3de542b7d rdf:first sg:person.01127603173.41
105 rdf:rest Nb5b2e1a5a58c43ad86132f3fe8030059
106 Nb5b2e1a5a58c43ad86132f3fe8030059 rdf:first sg:person.063042215.31
107 rdf:rest N3c6103e7a9194f59bf1bc68a8862c0aa
108 Nbbd7182b0b6c4439b6b9d0693da6fa8c schema:name dimensions_id
109 schema:value pub.1052371540
110 rdf:type schema:PropertyValue
111 Nbdf8db5a346645fc81290a2f99789c4d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Creatinine
113 rdf:type schema:DefinedTerm
114 Nbfbda98045494b5faebec33ddd2f83ae schema:name Springer Nature - SN SciGraph project
115 rdf:type schema:Organization
116 Nc9599eea59704d37a918e61ee15c6afe schema:volumeNumber 28
117 rdf:type schema:PublicationVolume
118 Ncc982d3848c746eba21e6d8dd4b9c86d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Myocardial Infarction
120 rdf:type schema:DefinedTerm
121 Ncfdacd602176400daf3a7cc726016867 rdf:first sg:person.0105361047.24
122 rdf:rest N9ef88f1e50bd45ca9b2f93f3de542b7d
123 Ndc8f32200f5a427584cf66e4b80f8838 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Humans
125 rdf:type schema:DefinedTerm
126 Ne052ce69553d4db7bde234cab2fcbc9d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Biotransformation
128 rdf:type schema:DefinedTerm
129 Ne7c7635808084121a27c3ea6ac54af16 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Male
131 rdf:type schema:DefinedTerm
132 Ne819ab9b83994081b14fb8152d799da6 schema:affiliation N1ff774273479467aac12ba123b18f60d
133 schema:familyName Wilen
134 schema:givenName G.
135 rdf:type schema:Person
136 Nece4417a103342088beec7484a0e390d schema:name doi
137 schema:value 10.1007/bf00635707
138 rdf:type schema:PropertyValue
139 Nf889027a37a944cfbc7bf36415606214 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Kinetics
141 rdf:type schema:DefinedTerm
142 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
143 schema:name Medical and Health Sciences
144 rdf:type schema:DefinedTerm
145 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
146 schema:name Clinical Sciences
147 rdf:type schema:DefinedTerm
148 sg:journal.1054337 schema:issn 0031-6970
149 1432-1041
150 schema:name European Journal of Clinical Pharmacology
151 rdf:type schema:Periodical
152 sg:person.0105361047.24 schema:affiliation https://www.grid.ac/institutes/grid.7737.4
153 schema:familyName Pentikäinen
154 schema:givenName P. J.
155 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0105361047.24
156 rdf:type schema:Person
157 sg:person.01127603173.41 schema:affiliation https://www.grid.ac/institutes/grid.10858.34
158 schema:familyName Huikuri
159 schema:givenName H.
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127603173.41
161 rdf:type schema:Person
162 sg:person.063042215.31 schema:affiliation https://www.grid.ac/institutes/grid.10858.34
163 schema:familyName Jounela
164 schema:givenName A. J.
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.063042215.31
166 rdf:type schema:Person
167 sg:pub.10.1007/bf00566315 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013146099
168 https://doi.org/10.1007/bf00566315
169 rdf:type schema:CreativeWork
170 sg:pub.10.1007/bf00613425 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012081526
171 https://doi.org/10.1007/bf00613425
172 rdf:type schema:CreativeWork
173 sg:pub.10.2165/00003088-197601060-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007331153
174 https://doi.org/10.2165/00003088-197601060-00001
175 rdf:type schema:CreativeWork
176 sg:pub.10.2165/00003088-197702050-00004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006080251
177 https://doi.org/10.2165/00003088-197702050-00004
178 rdf:type schema:CreativeWork
179 sg:pub.10.2165/00003495-197815050-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069122835
180 https://doi.org/10.2165/00003495-197815050-00002
181 rdf:type schema:CreativeWork
182 https://app.dimensions.ai/details/publication/pub.1074400604 schema:CreativeWork
183 https://app.dimensions.ai/details/publication/pub.1074400615 schema:CreativeWork
184 https://app.dimensions.ai/details/publication/pub.1082154003 schema:CreativeWork
185 https://doi.org/10.1002/cpt1975176669 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022507357
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1002/cpt19792611 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052709492
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1016/0002-9149(78)90851-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032568018
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1016/0006-2952(69)90318-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050812373
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1016/s0021-9673(00)82914-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011004768
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1016/s0021-9673(01)91823-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012518873
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1021/ac50039a032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1055010436
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1111/j.1365-2125.1982.tb02024.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1002298390
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1111/j.1749-6632.1971.tb46914.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1029210020
202 rdf:type schema:CreativeWork
203 https://doi.org/10.7326/0003-4819-78-4-499 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073730779
204 rdf:type schema:CreativeWork
205 https://www.grid.ac/institutes/grid.10858.34 schema:alternateName University of Oulu
206 schema:name Department of Medicine, University of Oulu, Finland
207 rdf:type schema:Organization
208 https://www.grid.ac/institutes/grid.7737.4 schema:alternateName University of Helsinki
209 schema:name Third Department of Medicine, University of Helsinki, Finland
210 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...